FUB-PB-22: Difference between revisions
CSV import |
No edit summary |
||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
== FUB-PB-22 == | == FUB-PB-22 == | ||
<gallery> | <gallery> | ||
File:FUB-PB-22 structure.png|FUB-PB-22 structure | File:FUB-PB-22 structure.png|FUB-PB-22 structure | ||
</gallery> | </gallery> | ||
Latest revision as of 21:02, 16 March 2025
FUB-PB-22 is a designer drug that belongs to the cannabinoid class. It is an ingredient in some types of synthetic cannabis products. FUB-PB-22 is known for its psychoactive effects and is often used for recreational purposes. However, it is illegal in many countries due to its potential for abuse and the health risks associated with its use.
History[edit]
FUB-PB-22 was first identified in Japan in 2013. It was found in synthetic cannabis products and has since been detected in similar products around the world. The drug is often sold under various brand names, and its exact composition can vary.
Effects[edit]
The effects of FUB-PB-22 are similar to those of tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis. Users may experience feelings of euphoria, altered perception, and increased appetite. However, FUB-PB-22 can also cause negative effects such as anxiety, paranoia, and hallucinations. In some cases, use of the drug has been linked to serious health problems, including heart attacks and seizures.
Legal status[edit]
FUB-PB-22 is illegal in many countries, including the United States, where it is classified as a Schedule I controlled substance. This means that it has a high potential for abuse and no accepted medical use. In the European Union, FUB-PB-22 is classified as a new psychoactive substance and is subject to control measures and sanctions.


